000 | 01559 a2200445 4500 | ||
---|---|---|---|
005 | 20250517083632.0 | ||
264 | 0 | _c20160816 | |
008 | 201608s 0 0 eng d | ||
022 | _a1096-0341 | ||
024 | 7 |
_a10.1016/j.virol.2016.02.021 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhirnov, O P | |
245 | 0 | 0 |
_aIntravirion cohesion of matrix protein M1 with ribonucleocapsid is a prerequisite of influenza virus infectivity. _h[electronic resource] |
260 |
_bVirology _cMay 2016 |
||
300 |
_a187-96 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
650 | 0 | 4 | _aChick Embryo |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 |
_aHemagglutinin Glycoproteins, Influenza Virus _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydrogen-Ion Concentration |
650 | 0 | 4 |
_aInfluenza A Virus, H3N2 Subtype _xdrug effects |
650 | 0 | 4 | _aMadin Darby Canine Kidney Cells |
650 | 0 | 4 |
_aNucleocapsid _xchemistry |
650 | 0 | 4 | _aProtons |
650 | 0 | 4 |
_aRimantadine _xpharmacology |
650 | 0 | 4 |
_aTrypsin _xpharmacology |
650 | 0 | 4 |
_aViral Matrix Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aVirion _xdrug effects |
650 | 0 | 4 | _aVirulence |
650 | 0 | 4 |
_aVirus Internalization _xdrug effects |
700 | 1 | _aManykin, A A | |
700 | 1 | _aRossman, J S | |
700 | 1 | _aKlenk, H D | |
773 | 0 |
_tVirology _gvol. 492 _gp. 187-96 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.virol.2016.02.021 _zAvailable from publisher's website |
999 |
_c25806008 _d25806008 |